Q-Line Biotech (NSE:QLINE) Other Current Payables: ₹179 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Other Current Payables?

Q-Line Biotech NSE:QLINE -5.15% 12 Other Current Payables is ₹179 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's Other Current Payables for the quarter that ended in Mar. 2025 was ₹179 Mil.

Q-Line Biotech's quarterly Other Current Payables declined from Mar. 2023 (₹40 Mil) to Mar. 2024 (₹34 Mil) but then increased from Mar. 2024 (₹34 Mil) to Mar. 2025 (₹179 Mil).

Q-Line Biotech's annual Other Current Payables declined from Mar. 2023 (₹40 Mil) to Mar. 2024 (₹34 Mil) but then increased from Mar. 2024 (₹34 Mil) to Mar. 2025 (₹179 Mil).

Q-Line Biotech Other Current Payables Related Terms

Q-Line Biotech Other Current Payables Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Other Current Payables Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Other Current Payables
40.15 33.60 178.66

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Other Current Payables 40.15 33.60 178.66
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹179 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Other Current Payables of ₹179 Mil as of Mar. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Other Current Payables too high?
Q-Line Biotech's current Other Current Payables is ₹179 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Other Current Payables compare to ABT and SYK?
Q-Line Biotech's Other Current Payables of ₹179 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Other Current Payables is ₹179 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Other Current Payables of ₹179 Mil. The current Other Current Payables is ₹179 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Other Current Payables is ₹179 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price